2026 Global: Blood Coagulation Testing Market -Competitive Review (2032) report
Description
The 2026 Global: Blood Coagulation Testing Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for blood coagulation testing market by geography and historical trend. The scope of the report extends to sizing of the blood coagulation testing market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The blood coagulation testing market is dominated by ten major companies: F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Diagnostica Stago Inc., Werfen, Danaher Corporation, Helena Laboratories Corporation, and Nihon Kohden Corporation. These leaders collectively drive innovation through advanced analyzers, reagents, and point-of-care systems, capturing significant market share amid growing demand for hemostasis diagnostics. F. Hoffmann-La Roche Ltd. (Switzerland) excels with high-throughput analyzers like the cobas t 711, integrating software for lab efficiency and investing heavily in R&D, with a 2% increase last year. Siemens Healthineers AG (Germany) offers scalable hemostasis solutions, including over 60 IVDR-ready assays and systems like CS-2500, bolstered by recent CN-3000/6000 integrations. Sysmex Corporation (Japan) leads via massive reagent production across 14 global sites and FDA-cleared analyzers like CN-6000 in June 2025.
Thermo Fisher Scientific Inc. (US) provides comprehensive instrumentation and reagents, supporting healthcare with USD 43.3 billion in revenue and innovations in diagnostics. Abbott Laboratories (US), with USD 40.72 billion revenue, delivers portable i-STAT systems for rapid point-of-care coagulation testing, emphasizing user-friendly solutions. Diagnostica Stago Inc. (France) specializes in over 350 hemostasis products, manufacturing 2,800 analyzers yearly and performing 750 tests per minute globally, with 20% workforce in R&D. Werfen (Spain) tops rankings with diverse portfolios and expansions like the GEM Premier 7000 in Europe in July 2025, featuring hemolysis detection. Danaher Corporation (US) leverages its Danaher Business System for automated diagnostics, expanding via acquisitions for IVDR-compliant workflows.
Helena Laboratories Corporation (US) focuses on electrophoresis and coagulation reagents, serving labs with reliable desktop systems. Nihon Kohden Corporation (Japan) contributes specialized analyzers, enhancing market fragmentation where top players hold 50-60% share. Medtronic (USD 32 billion revenue) adds point-of-care tools for clotting monitoring, though less dominant. These firms navigate fragmentation, with 40-50% market held by regional vendors, fueling competition through R&D and regulatory adaptations like 2025 CLIA POCT changes. Their global networks and innovations ensure precise testing for disorders like hemophilia, supporting projected growth to USD 4.26 billion by 2035.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for blood coagulation testing market by geography and historical trend. The scope of the report extends to sizing of the blood coagulation testing market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The blood coagulation testing market is dominated by ten major companies: F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Diagnostica Stago Inc., Werfen, Danaher Corporation, Helena Laboratories Corporation, and Nihon Kohden Corporation. These leaders collectively drive innovation through advanced analyzers, reagents, and point-of-care systems, capturing significant market share amid growing demand for hemostasis diagnostics. F. Hoffmann-La Roche Ltd. (Switzerland) excels with high-throughput analyzers like the cobas t 711, integrating software for lab efficiency and investing heavily in R&D, with a 2% increase last year. Siemens Healthineers AG (Germany) offers scalable hemostasis solutions, including over 60 IVDR-ready assays and systems like CS-2500, bolstered by recent CN-3000/6000 integrations. Sysmex Corporation (Japan) leads via massive reagent production across 14 global sites and FDA-cleared analyzers like CN-6000 in June 2025.
Thermo Fisher Scientific Inc. (US) provides comprehensive instrumentation and reagents, supporting healthcare with USD 43.3 billion in revenue and innovations in diagnostics. Abbott Laboratories (US), with USD 40.72 billion revenue, delivers portable i-STAT systems for rapid point-of-care coagulation testing, emphasizing user-friendly solutions. Diagnostica Stago Inc. (France) specializes in over 350 hemostasis products, manufacturing 2,800 analyzers yearly and performing 750 tests per minute globally, with 20% workforce in R&D. Werfen (Spain) tops rankings with diverse portfolios and expansions like the GEM Premier 7000 in Europe in July 2025, featuring hemolysis detection. Danaher Corporation (US) leverages its Danaher Business System for automated diagnostics, expanding via acquisitions for IVDR-compliant workflows.
Helena Laboratories Corporation (US) focuses on electrophoresis and coagulation reagents, serving labs with reliable desktop systems. Nihon Kohden Corporation (Japan) contributes specialized analyzers, enhancing market fragmentation where top players hold 50-60% share. Medtronic (USD 32 billion revenue) adds point-of-care tools for clotting monitoring, though less dominant. These firms navigate fragmentation, with 40-50% market held by regional vendors, fueling competition through R&D and regulatory adaptations like 2025 CLIA POCT changes. Their global networks and innovations ensure precise testing for disorders like hemophilia, supporting projected growth to USD 4.26 billion by 2035.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.